Publications by authors named "Sherly Mathen"
J Family Med Prim Care
January 2016
Article Synopsis
- The study aims to assess the levels of glycosylated hemoglobin (HbA1c) for ensuring safe fetal outcomes and explores how these levels relate to various adverse outcomes for fetuses.*
-
- Researchers followed first-time pregnant women without gestational diabetes at weeks 30-34 to measure HbA1c, analyzing the data for correlations with newborn health issues using statistical methods.*
-
- Results indicated HbA1c values ranged from 4.5% to 6%, with the lowest adverse outcomes occurring at 4.5%-5%, suggesting HbA1c is a useful tool for monitoring blood sugar levels during pregnancy.*
